Indolizine inhibitors of leukotriene production
    6.
    发明授权
    Indolizine inhibitors of leukotriene production 有权
    吲哚嗪抑制剂白三烯生产

    公开(公告)号:US08618300B2

    公开(公告)日:2013-12-31

    申请号:US13061996

    申请日:2009-08-25

    IPC分类号: C07D221/02

    CPC分类号: C07D471/04

    摘要: The present invention relates to compounds of formula (I): and pharmaceutically acceptable salt thereof, wherein X1 to X4, R1 to R4, A, B, D and m are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

    摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,其中X 1至X 4,R 1至R 4,A,B,D和m如本文所定义。 本发明还涉及包含这些化合物的药物组合物,使用这些化合物治疗各种疾病和病症的方法,制备这些化合物的方法和可用于这些方法的中间体。